| Literature DB >> 35663424 |
Elisa Gonçalves de Andrade1,2, Fernando González Ibáñez2,3, Marie-Ève Tremblay2,3,4,5,6,7.
Abstract
Suicide is a complex public health challenge associated worldwide with one death every 40 s. Research advances in the neuropathology of suicidal behaviors (SB) have defined discrete brain changes which may hold the key to suicide prevention. Physiological differences in microglia, the resident immune cells of the brain, are present in post-mortem tissue samples of individuals who died by suicide. Furthermore, microglia are mechanistically implicated in the outcomes of important risk factors for SB, including early-life adversity, stressful life events, and psychiatric disorders. SB risk factors result in inflammatory and oxidative stress activities which could converge to microglial synaptic remodeling affecting susceptibility or resistance to SB. To push further this perspective, in this Review we summarize current areas of opportunity that could untangle the functional participation of microglia in the context of suicide. Our discussion centers around microglial state diversity in respect to morphology, gene and protein expression, as well as function, depending on various factors, namely brain region, age, and sex.Entities:
Keywords: epigenetics; inflammation; microglia; neuronal support; oxidative stress; stress; suicide; synaptic plasticity
Year: 2022 PMID: 35663424 PMCID: PMC9158339 DOI: 10.3389/fncel.2022.839396
Source DB: PubMed Journal: Front Cell Neurosci ISSN: 1662-5102 Impact factor: 6.147
Full list of abbreviations and corresponding definitions.
| Abbreviation | Definition |
| 8-OHdG | 8-hydroxy-2′-deoxyguanosine |
| ACC | Anterior cingulate cortex |
| AD | Alzheimer’s disease |
| aMCC | Anterior midcingulate cortex |
| AMY | Amygdala |
| ATP | Adenosine triphosphate |
| BAM | Border-associated macrophages |
| BBB | Blood-brain barrier |
| BDNF | Brain-derived neurotrophic factor |
| BLA | Basolateral amygdala |
| BrdU | Bromodeoxyuridine |
| C1q | Complement C1q |
| CA |
|
| CCL2, MCP-1 | C-C motif chemokine ligand 2 |
| CCR2 | C-C chemokine receptor 2 |
| CD11b | Integrin subunit alpha M |
| CD163 | CD163 molecule |
| CD45 | Tyrosine phosphatase receptor type C |
| CD68 | CD68 molecule |
| CLDN5 | Claudin 5 |
| CNS | Central nervous system |
| CRP | C-reactive protein |
| CRS | Chronic restraint stress |
| CSDS | Chronic social defeat stress |
| CSF | Cerebrospinal fluid |
| CSF1R | Colony-stimulating factor 1 receptor |
| CUMS | Chronic unpredictable mild stress |
| CUS | Chronic unpredictable stress |
| CX3CL1 | C-X3-C motif chemokine ligand 1 |
| CX3CR1 | C-X3-C motif chemokine receptor 1 |
| dACC | Dorsal ACC |
| DCX | Doublecortin |
| DG | Dentate gyrus |
| DLPFC | Dorsolateral prefrontal cortex |
| DLS | Dorsolateral striatum |
| DM | Dark microglia |
| DPFWM | Dorsal prefrontal white matter |
| DRN | Dorsal raphe nucleus |
| ELA | Early-life adversity |
| ESI | Early-life social isolation |
| ESS | Early-life social stress |
| fMRI | Functional magnetic resonance imaging |
| FOSB | FBJ osteosarcoma oncogene B |
| GABA | Cortical gamma-aminobutyric acid |
| GC | Glucocorticoids |
| HEXB | Hexosaminidase |
| HIP | Hippocampus |
| HLA-DR | Major histocompatibility complex, class II, DR |
| HPA | Hypothalamus–pituitary–adrenal |
| HYP | Hypothalamus |
| IBA1 | Ionized calcium-binding adapter molecule 1 |
| IDO | Indoleamine 2,3-dioxygenase |
| IFN | Interferon |
| IL | Interleukin |
| IL1R1 | Interleukin 1 receptor type 1 |
| Ki67 | Nuclear protein Ki67 |
| LPS | Lipopolysaccharide |
| MAC387 | S100 calcium binding protein A9 |
| MDD | Major depressive disorder |
| MFG | Medial frontal gyrus |
| MIA | Maternal immune activation |
| MTN | Mediodorsal thalamic nucleus |
| NA |
|
| NFκB | Nuclear factor of kappa light polypeptide gene enhancer in B cells |
| NMDAR | N-methyl-D-aspartic acid receptor |
| NOX2 | Nicotinamide adenine dinucleotide phosphate oxidase |
| P2RY12 | P2Y purinoceptor 12 |
| PET | Positron emission tomography |
| PFC | Prefrontal cortex |
| PMI | Post-mortem interval |
| QUIN | Quinolinic acid |
| ROS | Reactive oxygen species |
| SALL1 | Spalt like transcription factor 1 |
| SB | Suicidal behaviors |
| SCZ | Schizophrenia |
| STG | Superior temporal gyrus |
| SZ | Subventricular zone |
| TBR2 | Eomes |
| TDO | Tryptophan 2,3-dioxygenase |
| TLM | Thalamus |
| TLR | Toll-like receptor |
| TMEM119 | Transmembrane protein 119 |
| TNF | Tumor necrosis factor |
| TREM2 | Triggering receptor expressed on myeloid cells 2 |
| TSPO | Translocator protein |
| VLPFC | Ventrolateral prefrontal cortex |
| VPFWM | Ventral prefrontal white matter |
FIGURE 1Microglia participate in pathways altered upon suicidal behaviors. (1) As a result of stress-susceptibility, inflammation in the periphery (a) can contribute to blood-brain barrier (BBB) disruption (b) and infiltration of peripheral cells or border-associated macrophages (BAM) (c) to the central nervous system (CNS) parenchyma. Stress-induced inflammatory (d) and oxidative stress (e) molecules, such as cytokines, reactive oxygen species or adenosine triphosphate, work in a positive feedback loop that could affect microglial synaptic plasticity regulation (f), and increase suicidal behaviors (SB) risk. (2) SB risk factors, including distal early-life adversity (ELA) and proximal major depressive disorder (MDD), are associated with microglial priming, in which elevated expression of genes related to phagocytosis, cellular proliferation, and vesicular release result in exacerbated inflammatory responses upon exposure to subsequent challenges, as well as to impaired synaptic development and function. (3) The regional diversity of microglia possibly participates in determining susceptibility to inflammation induced by SB risk factors. Region-specific differences in gene or protein expression of ionized calcium-binding adapter molecule 1 (IBA1), major histocompatibility complex class II, DR (HLA-DR), CX3C chemokine receptor 1 (CX3CR1), transmembrane protein 119 (TMEM119), as well as in density are observed in post-mortem CNS samples from individuals who died by suicide. (4) Similarly, distinct CNS areas likely have different oxidative stress responses to inflammation. Oxidative stress induced by inflammation is thought to affect mitochondrial and tryptophan metabolism, which may lead to an increased activity of microglial indoleamine 2,3-dioxygenase 1 (IDO), an enzyme that breaks tryptophan (TRP) down into kynurenine (KYN). Increased KYN to TRP ratio could decrease serotonin (SER) and gamma-aminobutyric acid (GABA) signaling, whilst elevating glutamate (GLU) excitotoxity in individuals with SB. Altogether, the multiple synaptic plasticity-related pathways implicate microglia in SB, warranting further investigation.